siRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs

Drug Discovery Today

Volumn 14, Issue 17-18, 2009, Pages 851-858

  Hajeri, Praveensingh B ^a   Singh, Sunit Kumar ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

DRUG DESIGN; GENE TARGETING; NONHUMAN; REVIEW; RNA INTERFERENCE; RNA SYNTHESIS;

DRUG DESIGN; DRUG STABILITY; GENE KNOCKDOWN TECHNIQUES; HUMANS; MODELS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SOFTWARE;

EID: 69549105796     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.06.001     Document Type: Review

References (89)

1. Katiyar-Agarwal S., et al. A pathogen-inducible endogenous siRNA in plant immunity. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18002-18007
2. Navarro L., et al. A plant miRNA contributes to antibacterial resistance by repressing auxin signaling. Science 312 (2006) 436-439
3. Fire A., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
4. Yi R., et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17 (2003) 3011-3016
5. Singh S.K., et al. MicroRNAs - micro in size but macro in function. FEBS J. 275 20 (2008) 4929-4944
6. Mathonnet G., et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317 (2007) 1764-1767
7. Valencia-Sanchez M.A., et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20 (2006) 515-524
8. Guil S., and Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol. 41 1 (2009) 87-95
9. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
10. Elbashir S.M., et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
11. Jiang P., et al. RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching. Comput. Methods Progr. Biomed. 87 (2007) 230-238
12. Huesken D., et al. Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23 (2005) 995-1001
13. Naito Y., et al. siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res. 32 Web Server issue (2004) W124-W129
14. Dudek P., and Picard D. TROD: T7 RNAi oligo designer. Nucleic Acids Res. 32 Web Server issue (2004) W121-W123
15. Naito Y., et al. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences. Nucleic Acids Res. 34 Web Server issue (2006) W448-450
16. Lu Z.J., and Mathews D.H. OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics. Nucleic Acids Res. 36 Web Server issue (2008) W104-108
17. Shah J.K., et al. sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database. BMC Bioinformatics 8 (2007) 178
18. Yuan B., et al. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32 Web Server issue (2004) W130-134
19. Elbashir S.M., et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20 (2001) 6877-6888
20. Akaneya Y., et al. RNAi-induced gene silencing by local electroporation in targeting brain region. J. Neurophysiol. 93 (2005) 594-602
21. Silva J.M., et al. Free energy lights the path toward more effective RNAi. Nat. Genet. 35 (2003) 303-305
22. Hsieh A.C., et al. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 32 (2004) 893-901
23. Ui-Tei K., et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32 (2004) 936-948
24. Kim D.H., et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23 (2005) 222-226
25. Siolas D., et al. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23 (2005) 227-231
26. Reynolds A., et al. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
27. Jagla B., et al. Sequence characteristics of functional siRNAs. RNA 11 (2005) 864-872
28. Shabalina S.A., et al. Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics 7 (2006) 65
29. Grimson A., et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27 (2007) 91-105
30. Rudnick S.I., et al. Effects of local mRNA structure on posttranscriptional gene silencing. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13787-13792
31. Lu Z.J., and Mathews D.H. Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Res. 36 (2008) 640-647
32. Jackson A.L., et al. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21 (2003) 635-637
33. Birmingham A., et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 3 (2006) 199-204
34. Xuan B., et al. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs. Virus Res. 118 (2006) 150-155
35. Kittler R., and Buchholz F. Functional genomic analysis of cell division by endoribonuclease-prepared siRNAs. Cell Cycle 4 (2005) 564-567
36. Jackson A.L., et al. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA 12 (2006) 1197-1205
37. Chen P.Y., et al. Strand-specific 5′-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity. RNA 14 (2008) 263-274
38. Fedorov Y., et al. Off-target effects by siRNA can induce toxic phenotype. RNA 12 (2006) 1188-1196
39. Seila A.C., and Sharp P.A. Small RNAs tell big stories in Whistler. Nat. Cell Biol. 10 (2008) 630-633
40. Ui-Tei K., et al. Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect. Nucleic Acids Res. 36 (2008) 2136-2151
41. Puri N., et al. LNA incorporated siRNAs exhibit lower off-target effects compared to 2′-O-methoxy in cell phenotypic assays and microarray analysis. Nucleic Acids Symp. Ser. (Oxf.) 52 (2008) 25-26
42. Elmen J., et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33 (2005) 439-447
43. Wahlestedt C., et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5633-5638
44. Sledz C.A., et al. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 (2003) 834-839
45. Kariko K., et al. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172 (2004) 6545-6549
46. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348 (2005) 1079-1090
47. Hornung V., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
48. Judge A.D., et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
49. Sioud M. Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur. J. Immunol. 36 (2006) 1222-1230
50. Song E., et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23 (2005) 709-717
51. Judge A.D., et al. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13 (2006) 494-505
52. Marques J.T., et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24 (2006) 559-565
53. Hornung V., et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
54. Wang Z., et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23 (2005) 321-328
55. Kim D.H., et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22 (2004) 321-325
56. Gondai T., et al. Short-hairpin RNAs synthesized by T7 phage polymerase do not induce interferon. Nucleic Acids Res. 36 (2008) e18
57. Gondai T., et al. Lack of interferon (IFN) response to T7 Transcribed pppG (n)(n = 2, 3)-shRNA. Nucleosides Nucleotides Nucleic Acids 26 (2007) 805-808
58. Robbins M.A., et al. Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat. Biotechnol. 24 (2006) 566-571
59. Wang L., et al. Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J. Clin. Invest. 110 (2002) 1175-1184
60. Heil F., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
61. Grabarek J.B., et al. Efficient delivery of dsRNA into zona-enclosed mouse oocytes and preimplantation embryos by electroporation. Genesis 32 (2002) 269-276
62. Yang S., et al. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell Biol. 21 (2001) 7807-7816
63. Billy E., et al. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14428-14433
64. Grimm D., et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
65. Narvaiza I., et al. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing. J. Virol. 80 (2006) 12236-12247
66. Sano M., et al. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection. Nucleic Acids Res. 36 18 (2008) 5812-5821
67. Miller V.M., et al. Allele-specific silencing of dominant disease genes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7195-7200
68. Miller V.M., et al. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res. 32 (2004) 661-668
69. Rodriguez-Lebron E., and Paulson H.L. Allele-specific RNA interference for neurological disease. Gene Ther. 13 (2006) 576-581
70. Ohnishi Y., et al. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS ONE 3 (2008) e2248
71. Ohnishi Y., et al. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3′- or 5′-end of the sense-stranded siRNA element. Biochem. Biophys. Res. Commun. 329 (2005) 516-521
72. Schwarz D.S., et al. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet. 2 (2006) e140
73. Zimmermann T.S., et al. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
74. Corey D.R. Chemical modification: the key to clinical application of RNA interference?. J. Clin. Invest. 117 (2007) 3615-3622
75. Harborth J., et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 13 (2003) 83-105
76. Soutschek J., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
77. Kraynack B.A., and Baker B.F. Small interfering RNAs containing full 2′-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity. RNA 12 (2006) 163-176
78. Hall A.H., et al. RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res. 32 (2004) 5991-6000
79. Mantei A., et al. siRNA stabilization prolongs gene knockdown in primary T lymphocytes. Eur. J. Immunol. 38 (2008) 2616-2625
80. Braasch D.A., et al. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42 (2003) 7967-7975
81. Swayze E.E., et al. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res. 35 (2007) 687-700
82. Dowler T., et al. Improvements in siRNA properties mediated by 2′-deoxy-2′-fluoro-beta-d-arabinonucleic acid (FANA). Nucleic Acids Res. 34 (2006) 1669-1675
83. Watts J.K., et al. 2′-Fluoro-4′-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity. Nucleic Acids Res. 35 (2007) 1441-1451
84. Murao S., et al. Suppression of bcr-abl mRNA by chemically modified siRNA. Nucleic Acids Symp. Ser. (Oxf.) 52 (2008) 499-500
85. Ittig D., et al. Tc-DNA modified siRNA. Nucleic Acids Symp. Ser. (Oxf.) 52 (2008) 501-502
86. Gong W., et al. Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics 7 (2006) 516
87. Truss M., et al. HuSiDa - the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells. Nucleic Acids Res. 33 Database issue (2005) D108-111
88. Chalk A.M., et al. siRNAdb: a database of siRNA sequences. Nucleic Acids Res. 33 Database issue (2005) D131-134
89. Ren Y., et al. siRecords: an extensive database of mammalian siRNAs with efficacy ratings. Bioinformatics 22 (2006) 1027-1028